16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Transient CD4 + T Cell Depletion Results in Delayed Development of Functional Vaccine-Elicited Antibody Responses

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          We have recently demonstrated that CD4 + T cell help is required at the time of adenovirus (Ad) vector immunization for the development of functional CD8 + T cell responses, but the temporal requirement for CD4 + T cell help for the induction of antibody responses remains unclear. Here we demonstrate that induction of antibody responses in C57BL/6 mice can occur at a time displaced from the time of Ad vector immunization by depletion of CD4 + T cells. Transient depletion of CD4 + T cells at the time of immunization delays the development of antigen-specific antibody responses but does not permanently impair their development or induce tolerance against the transgene. Upon CD4 + T cell recovery, transgene-specific serum IgG antibody titers develop and reach a concentration equivalent to that in undepleted control animals. These delayed antibody responses exhibit no functional defects with regard to isotype, functional avidity, expansion after boosting immunization, or the capacity to neutralize a simian immunodeficiency virus (SIV) Env-expressing pseudovirus. The development of this delayed transgene-specific antibody response is temporally linked to the expansion of de novo antigen-specific CD4 + T cell responses, which develop after transient depletion of CD4 + T cells. These data demonstrate that functional vaccine-elicited antibody responses can be induced even if CD4 + T cell help is provided at a time markedly separated from the time of vaccination.

          IMPORTANCE CD4 + T cells have a critical role in providing positive help signals to B cells, which promote robust antibody responses. The paradigm is that helper signals must be provided immediately upon antigen exposure, and their absence results in tolerance against the antigen. Here we demonstrate that, in contrast to the current model that the absence of CD4 + T cell help at priming results in long-term antibody nonresponsiveness, antibody responses can be induced by adenovirus vector immunization or alum-adjuvanted protein immunization even if CD4 + T cell help is not provided until >1 month after immunization. These data demonstrate that the time when CD4 + T cell help signals must be provided is more dynamic and flexible than previously appreciated. These data suggest that augmentation of CD4 + T cell helper function even after the time of vaccination can enhance vaccine-elicited antibody responses and thereby potentially enhance the immunogenicity of vaccines in immunocompromised individuals.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Lineage relationship and protective immunity of memory CD8 T cell subsets.

          Memory CD8 T cells can be divided into two subsets, central (T(CM)) and effector (T(EM)), but their lineage relationships and their ability to persist and confer protective immunity are not well understood. Our results show that T(CM) have a greater capacity than T(EM) to persist in vivo and are more efficient in mediating protective immunity because of their increased proliferative potential. We also demonstrate that, following antigen clearance, T(EM) convert to T(CM) and that the duration of this differentiation is programmed within the first week after immunization. We propose that T(CM) and T(EM) do not necessarily represent distinct subsets, but are part of a continuum in a linear naive --> effector --> T(EM) --> T(CM) differentiation pathway.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Visualization of specific B and T lymphocyte interactions in the lymph node.

            Early events in the humoral immune response were visualized in lymph nodes by simultaneous tracking of antigen-specific CD4 T and B cells after immunization. The T cells were initially activated in the T cell areas when the B cells were still randomly dispersed in the B cell-rich follicles. Both populations then migrated to the edges of the follicles and interacted there, resulting in CD154-dependent B cell proliferation and germinal center formation. These results provide visual documentation of cognate T-B cell interactions and localize them to the follicular border.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys.

              Preclinical studies of viral vector-based HIV-1 vaccine candidates have previously shown partial protection against neutralization-resistant virus challenges in rhesus monkeys. In this study, we evaluated the protective efficacy of adenovirus serotype 26 (Ad26) vector priming followed by purified envelope (Env) glycoprotein boosting. Rhesus monkeys primed with Ad26 vectors expressing SIVsmE543 Env, Gag, and Pol and boosted with AS01B-adjuvanted SIVmac32H Env gp140 demonstrated complete protection in 50% of vaccinated animals against a series of repeated, heterologous, intrarectal SIVmac251 challenges that infected all controls. Protective efficacy correlated with the functionality of Env-specific antibody responses. Comparable protection was also observed with a similar Ad/Env vaccine against repeated, heterologous, intrarectal SHIV-SF162P3 challenges. These data demonstrate robust protection by Ad/Env vaccines against acquisition of neutralization-resistant virus challenges in rhesus monkeys.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                J Virol
                J. Virol
                jvi
                jvi
                JVI
                Journal of Virology
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                0022-538X
                1098-5514
                10 February 2016
                14 April 2016
                1 May 2016
                14 April 2016
                : 90
                : 9
                : 4278-4288
                Affiliations
                [a ]Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
                [b ]Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, USA
                Author notes
                Address correspondence to Dan H. Barouch, dbarouch@ 123456bidmc.harvard.edu .

                Citation Provine NM, Badamchi-Zadeh A, Bricault CA, Penaloza-MacMaster P, Larocca RA, Borducchi EN, Seaman MS, Barouch DH. 2016. Transient CD4 + T cell depletion results in delayed development of functional vaccine-elicited antibody responses. J Virol 90:4278–4288. doi: 10.1128/JVI.00039-16.

                Article
                00039-16
                10.1128/JVI.00039-16
                4836333
                26865713
                e763a938-0d34-4c89-96c1-fa9e623a740b
                Copyright © 2016 Provine et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 6 January 2016
                : 5 February 2016
                Page count
                Figures: 7, Tables: 0, Equations: 0, References: 51, Pages: 11, Words: 8979
                Funding
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) http://dx.doi.org/10.13039/100000060
                Award ID: AI078526
                Award ID: AI096040
                Award Recipient : Dan H. Barouch
                Funded by: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) http://dx.doi.org/10.13039/100000060
                Award ID: AI007245
                Award ID: AI007387
                Award Recipient : Pablo Penaloza-MacMaster
                Funded by: Bill and Melinda Gates Foundation http://dx.doi.org/10.13039/100000865
                Award ID: OPP1033091
                Award Recipient : Dan H. Barouch
                Categories
                Vaccines and Antiviral Agents

                Microbiology & Virology
                Microbiology & Virology

                Comments

                Comment on this article